Quantum Leap award applications are due September 30th.

Learn More

Powerful Discoveries Defeat Disease

The Indiana Biosciences Research Institute (IBRI) is a leading translational research institute that advances academic and industry science through collaboration to improve patient health outcomes.

Scientific Areas

IBRI's Strategy

Today’s research is being driven by significant advances in our abilities to study complex disease processes and identify powerful discoveries to defeat disease. To reflect the evolving nature of life sciences research and encourage synergies through collaboration, we’re enhancing our integrated capabilities and adding depth to how we approach patient-informed translational science.

Our focus as a translational research institute on collaboration is enhanced by our unique position in Indianapolis’ 16 Tech, which is a 50-acre mixed-use innovation district that seeks to support and foster cross-sector collaboration, promote innovation and boost economic growth and prosperity. Our headquarters in 16 Tech serves as a nexus point that connects us within minutes to key collaborators at academic institutions, life sciences companies and biotechnology startups.

Scientist working in the lab

Quantum Leap Award

Applications now open for the Quantum Leap Award.

Is your startup focused on therapeutics or diagnostics relating to neurodegenerative and neuromuscular research? Learn more about the new Quantum Leap Award and apply now.